Abbott Laboratories (NYSE:ABT)
| 97.08 Delayed Data As of Mar 28 |  -0.03 / -0.03%Today’s Change | 93.25 Today|||52-Week Range 124.36 | -11.58% Year-to-Date |
Latest ABT News | Press Releases
| 2 Dividend Stocks Down 11% to 22% to Buy and Hold Forever Mar 28 / MotleyFool.com - Paid Partner Content | Here's Why You Should Retain Abbott (ABT) Stock for Now Mar 22 / Zacks.com - Paid Partner Content |
| Abbott (ABT) Outpaces Stock Market Gains: What You Should Know Mar 27 / Zacks.com - Paid Partner Content | Should You Invest in the iShares U.S. Medical Devices ETF (IHI)? Mar 21 / Zacks.com - Paid Partner Content |
| Abbott's (ABT) CardioMEMS Favors Heart Failure Management Mar 27 / Zacks.com - Paid Partner Content | Abbott (ABT) Stock Moves 0.89%: What You Should Know Mar 20 / Zacks.com - Paid Partner Content |
| Wall Street Analysts See Abbott (ABT) as a Buy: Should You Invest? Mar 24 / Zacks.com - Paid Partner Content | Abbott (ABT) Diabetes Arm Growth Robust Amid Macroeconomic Woes Mar 17 / Zacks.com - Paid Partner Content |
| 2 High-Yield Dividend Stocks You Won't Regret Buying Right Now Mar 23 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 97.11 |
| Today’s open | 98.11 |
| Day’s range | 96.61 - 98.24 |
| Volume | 4,815,443 |
| Average volume (3 months) | 4,917,545 |
| Market cap | $170.4B |
Data as of 4:00pm ET, 03/28/2023
Growth & Valuation
| Earnings growth (last year) | -0.71% |
| Earnings growth (this year) | -17.55% |
| Earnings growth (next 5 years) | +3.50% |
| Revenue growth (last year) | +1.34% |
| P/E ratio | 24.8 |
| Price/Sales | 4.44 |
| Price/Book | 4.64 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BSXBoston Scientific Co... | +0.27 | +0.56% |
| BDXBecton Dickinson and... | -0.04 | -0.02% |
| DXCMDexcom Inc | -2.25 | -1.94% |
| ZBHZimmer Biomet Holdin... | +0.01 | +0.01% |
Data as of 4:00pm ET, 03/28/2023
Financials
| Next reporting date | April 19, 2023 |
| EPS forecast (this quarter) | $0.99 |
| Annual revenue (last year) | $43.7B |
| Annual profit (last year) | $6.9B |
| Net profit margin | 15.82% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Abbott Park, Illinois |
Forecasts
